January 30, 2019
A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Read More
January 30, 2019
A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530
Read More
January 30, 2019
Effectiveness of Paritaprevir/Ritonavir – Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C – An Observational Study in Belgium
Read More
January 30, 2019
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Read More
January 30, 2019
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Read More
January 30, 2019
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Read More
January 30, 2019
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Read More
December 10, 2018
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
Read More
X